Mark T Ziolo Selected Research

Troponin I

1/2023	The lack of Troponin I Ser-23/24 phosphorylation is detrimental to in vivo cardiac function and exacerbates cardiac disease.
7/2014	Combined troponin I Ser-150 and Ser-23/24 phosphorylation sustains thin filament Ca(2+) sensitivity and accelerates deactivation in an acidic environment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark T Ziolo Research Topics

Disease

10	Heart Failure 03/2023 - 04/2004
3	Fibrosis (Cirrhosis) 03/2023 - 01/2022
3	Cardiomyopathies (Cardiomyopathy) 03/2023 - 01/2008
3	Heart Diseases (Heart Disease) 01/2023 - 01/2008
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2023 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2017 - 07/2014
2	Reperfusion Injury 02/2017 - 06/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2016 - 04/2010
1	Cicatrix (Scar) 03/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2023
1	Inflammation (Inflammations) 01/2022
1	Insulin Resistance 01/2022
1	Obesity 01/2022
1	Myocardial Infarction 01/2022
1	Atrial Remodeling 04/2017
1	Diastolic Heart Failure 01/2017
1	Systolic Heart Failure 01/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2016
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2016
1	Splenomegaly 09/2013
1	Hematologic Neoplasms (Hematological Malignancy) 09/2013
1	Multiple Sclerosis 09/2013
1	Contracture 01/2012
1	Ventricular Tachycardia 06/2008

Drug/Important Bio-Agent (IBA)

3	CalciumIBA 01/2018 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 11/2017 - 05/2015
3	Peroxynitrous Acid (Peroxynitrite)IBA 02/2017 - 01/2008
3	Adrenergic Agents (Adrenergic Drugs)IBA 06/2015 - 01/2008
2	Troponin IIBA 01/2023 - 07/2014
2	salicylhydroxamic acid (SHAM)IBA 12/2022 - 01/2022
1	TenascinIBA 03/2023
1	CollagenIBA 03/2023
1	DystrophinIBA 03/2023
1	UtrophinIBA 03/2023
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2022
1	Angiotensin IIIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2017
1	Particulate MatterIBA 04/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2017
1	Adenosine Triphosphatases (ATPase)IBA 02/2017
1	nitroxylIBA 01/2017
1	ProdrugsIBA 01/2017
1	Calcium-Binding ProteinsIBA 07/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2015
1	Claudin-5IBA 05/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2014
1	Protein Isoforms (Isoforms)IBA 06/2014
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2013
1	SphingosineIBA 09/2013
1	Fingolimod Hydrochloride (FTY720)FDA Link 09/2013
1	Immunologic Factors (Immunomodulators)IBA 09/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2012
1	StaurosporineIBA 01/2012
1	SolutionsIBA 01/2012
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2012
1	RyanodineIBA 07/2010
1	Phosphotransferases (Kinase)IBA 07/2010
1	CytosineIBA 04/2010
1	ThymidineIBA 04/2010
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 04/2009
1	zinterolIBA 06/2008
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 06/2008
1	beta Adrenergic ReceptorsIBA 04/2004

Therapy/Procedure

2	Therapeutics 03/2023 - 01/2017
1	Ligation 01/2023
1	Endovascular Aneurysm Repair 01/2023
1	Transplantation 01/2022